{
    "nct_id": "NCT06662058",
    "official_title": "Ototoxicity Monitoring and Remote Audiometry",
    "brief_title": "Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation",
    "cancer_type_display": "A study monitoring treatment-related hearing loss for patients with various types of head and neck squamous cell carcinoma who are receiving cisplatin and/or radiation therapy.",
    "cancer_tags": [
      "Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8",
      "Cutaneous Squamous Cell Carcinoma of the Head and Neck",
      "Head and Neck Carcinoma of Unknown Primary",
      "Head and Neck Squamous Cell Carcinoma",
      "Hypopharyngeal Squamous Cell Carcinoma",
      "Laryngeal Squamous Cell Carcinoma",
      "Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck",
      "Metastatic Head and Neck Squamous Cell Carcinoma",
      "Metastatic Hypopharyngeal Squamous Cell Carcinoma",
      "Metastatic Laryngeal Squamous Cell Carcinoma",
      "Metastatic Nasopharyngeal Squamous Cell Carcinoma",
      "Metastatic Oral Cavity Squamous Cell Carcinoma",
      "Metastatic Oropharyngeal Squamous Cell Carcinoma",
      "Metastatic Paranasal Sinus Squamous Cell Carcinoma",
      "Nasopharyngeal Squamous Cell Carcinoma",
      "Oral Cavity Squamous Cell Carcinoma",
      "Oropharyngeal Squamous Cell Carcinoma",
      "Paranasal Sinus Squamous Cell Carcinoma",
      "Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck",
      "Recurrent Head and Neck Squamous Cell Carcinoma",
      "Recurrent Hypopharyngeal Squamous Cell Carcinoma",
      "Recurrent Laryngeal Squamous Cell Carcinoma",
      "Recurrent Nasopharyngeal Squamous Cell Carcinoma",
      "Recurrent Oral Cavity Squamous Cell Carcinoma",
      "Recurrent Oropharyngeal Squamous Cell Carcinoma",
      "Recurrent Paranasal Sinus Squamous Cell Carcinoma",
      "Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8",
      "Stage IV Hypopharyngeal Carcinoma AJCC v8",
      "Stage IV Laryngeal Cancer AJCC v8",
      "Stage IV Lip and Oral Cavity Cancer AJCC v8",
      "Stage IV Nasopharyngeal Carcinoma AJCC v8",
      "Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8",
      "Stage IV Sinonasal Cancer AJCC v8"
    ],
    "link_to_trial": "https://clinicaltrials.gov/study/NCT06662058",
    "phase": null,
    "recruitment_status": "RECRUITING",
    "last_update_date": "2025-04-10",
    "enrollment": 118,
    "min_age": 18,
    "max_age": null,
    "sex": "ALL",
    "is_metastatic_allowed": true,
    "performance_status_scale": null,
    "performance_status_values": null,
    "min_prior_lines": 0,
    "max_prior_lines": null,
    "prior_treatments_required": null,
    "prior_treatments_excluded": null,
    "principal_investigator": "Nicole C Schmitt, MD, FACS",
    "site_name": "Emory Midtown University Hospital/Winship Cancer Institute",
    "contact_email": "nicole.cherie.schmitt@emory.edu",
    "contact_phone": "404-778-1900",
    "locations": [
      {
        "facility": "Emory Midtown University Hospital/Winship Cancer Institute",
        "status": "RECRUITING",
        "city": "Atlanta",
        "state": "Georgia",
        "zip": "30322",
        "country": "United States",
        "contacts": [
          {
            "name": "Nicole C. Schmitt",
            "role": "CONTACT",
            "phone": "404-778-1900",
            "email": "nicole.cherie.schmitt@emory.edu"
          },
          {
            "name": "Nicole C. Schmitt",
            "role": "PRINCIPAL_INVESTIGATOR"
          }
        ],
        "geoPoint": {
          "lat": 33.749,
          "lon": -84.38798
        }
      }
    ],
    "key_inclusion_summary": [
      "Adult patients aged 18 or older.",
      "Must have pathologically proven head and neck squamous cell carcinoma (HNSCC).",
      "Patients can have previously untreated or recurrent/metastatic disease.",
      "Will be treated with cisplatin chemotherapy and/or radiation.",
      "Life expectancy of more than 3 months."
    ],
    "key_exclusion_summary": [
      "Patients with profound hearing loss in both ears, which precludes an accurate hearing test.",
      "Patients who are unable to participate in a hearing test as per the investigator's judgment."
    ]
  }
  